Tenofovir disoproxil fumarate withdrawal and cardiovascular risk

Lancet HIV. 2023 Jan;10(1):e8-e9. doi: 10.1016/S2352-3018(22)00362-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents* / adverse effects
  • Cardiovascular Diseases* / epidemiology
  • HIV Infections* / drug therapy
  • Heart Disease Risk Factors
  • Humans
  • Risk Factors
  • Tenofovir / adverse effects

Substances

  • Tenofovir
  • Anti-HIV Agents